Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: The potential molecular mechanisms

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 8, 2014, Pages 1113-1126

  Li, Q ^a   Zhuang, Q K ^a   Yang, J N ^a   Zhang, Y Y ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Molecular mechanisms; Statins

Indexed keywords

CASPASE 3; CELL ADHESION MOLECULE; CHEMOKINE; ENDOTHELIN; ENDOTHELIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN KINASE B; RHO FACTOR; TOLL LIKE RECEPTOR; AUTACOID; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; BRAIN ISCHEMIA; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; ISOPRENYLATION; NEUROPROTECTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; UPREGULATION; ANIMAL; BRAIN; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION MEDIATORS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84902154187     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. LLOYD-JONES D, ADAMS R, CARNETHON M, DE SIMONE G, FERGUSON TB, FLEGAL K, FORD E, FURIE K, GO A, GREENLUND K, HAASE N, HAILPERN S, HO M, HOWARD V, KISSELA B, KITTNER S, LACKLAND D, LISABETH L, MARELLI A, MCDERMOTT M, MEIGS J, MOZAFFARIAN D, NICHOL G, O'DONNELL C, ROGER V, ROSAMOND W, SACCO R, SORLIE P, STAFFORD R, STEINBERGER J, THOM T, WASSERTHIEL-SMOLLER S, WONG N, WYLIE-ROSETT J, HONG Y. Heart disease and stroke statisticse 2009 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 21-181.
2. RG GILBERTO GONZÁLEZ RG, HIIRSCH JA, LEV MH, SCHAEFER PW, SCHWAMM LH. Acute Ischemic Stroke: imaging and intervention. Springer, 2011
3. HOU R, GOLDBERG AC. Lowering low-density lipoprotein cholesterol: Statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Endocrinol Metab Clin North Am 2009; 38: 79-97.
4. ARANCIBIA SA, BELTRÁN CJ, AGUIRRE IM, SILVA P, PERALTA AL, MALINARICH F, HERMOSO MA. Toll-like receptors are key participants in innate immune responses. Biol Res 2007; 40: 97-112. (Pubitemid 350111016)
5. LU,YC, YEH WC, OHASHI PS.LPS/TLR4 signal transduction pathway. Cytokine 2008; 42: 145-151.
6. HYAKKOKU K, HAMANAKA J, TSURUMA K, SHIMAZAWA M, TANAKA H, UEMATSU S, AKIRA S, INAGAKI N, NAGAI H, HARA H. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 2010; 171: 258-267.
7. CASO JR, PRADILLO JM, HURTADO O, LEZA JC, MORO MA, LIZASOAIN I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 2008; 39: 1314-1320. (Pubitemid 351440707)
8. CASO JR, PRADILLO JM, HURTADO O, LORENZO P, MORO MA, LIZASOAIN I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007; 115: 1599-1608. (Pubitemid 46648645)
9. SHIMAZU R, AKASHI S, OGATA H, NAGAI Y, FUKUDOME K, MIYAKE K, KIMOTO M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782. (Pubitemid 29272694)
10. WRIGHT SD, RAMOS RA, TOBIAS PS, ULEVITCH RJ, MATHISON JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
11. TRIANTAFILOU M, TRIANTAFILOU K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002; 23: 301-304. (Pubitemid 34628773)
12. TRIANTAFILOU K, TRIANTAFILOU M, DEDRICK RL. A CD14-independent LPS receptor cluster. Nat Immunol 2001; 2: 338-345. (Pubitemid 33706345)
13. DA SILVA CORREIA J, SOLDAU K, CHRISTEN U, TOBIAS PS, ULEVITCH RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276: 21129-21135.
14. AKASHI S, SAITOH S, WAKABAYASHI Y, KIKUCHI T, TAKAMURA N, NAGAI Y, KUSUMOTO Y, FUKASE K, KUSUMOTO S, ADACHI Y, KOSUGI A, MIYAKE K. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med 2003; 198: 1035-1042. (Pubitemid 37248619)
15. ANEJA R, ODOMS K, DUNSMORE K, SHANLEY TP, WONG HR. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol 2006; 177: 7184-7192. (Pubitemid 44715087)
16. TRIANTAFILOU M, TRIANTAFILOU K. Heat-shock protein 70 and heat-shock protein 90 associate with Tolllike receptor 4 in response to bacter ial lipopolysaccharide. Biochem Soc Trans 2004; 32: 636-639 (Pubitemid 39120403)
17. WAGSTAFF MJ, COLLAO-MORAES Y, ASPEY BS, COFFIN RS, HARRISON MJ, LATCHMAN DS, DE BELLEROCHE JS. Focal cerebral ischaemia increases the levels of several classes of heat shock proteins and their corresponding mRNAs. Brain Res Mol Brain Res 1996; 42: 236-244. (Pubitemid 27035752)
18. GENTH-ZOTZ S, BOLGER AP, KALRA PR, VON HAEHLING S, DOEHNER W, COATS AJ, VOLK HD, ANKER SD. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol 2004; 96: 397-401. (Pubitemid 39099502)
19. GAO Y, FANG X, TONG Y, LIU Y, ZHANG B. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother 2009; 63: 442-450.
20. HUA F, MA J, HA T, KELLEY JL, KAO RL, SCHWEITZER JB, KALBFLEISCH JH, WILLIAMS DL, LI C. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/ reperfusion injury in mice. Brain Res 2009; 1262: 100-108.
21. SIRONI L, BANFI C, BRIOSCHI M, GELOS P, GUERRINI U, NOBILI E, GIANELLA A, PAOLETTI R, TREMOLI E, CIMINO M. Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment. Neurobiol Dis 2006; 22: 445-451.
22. WANG L, ZHANG X, LIU L, CUI J,FU HB, WANG JZ. Atorvastatin protects rat brains against permanent focal ischemia and down regulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kB expression. Neurosci Lett 2010; 471: 152-156.
23. HUGHES PM, ALLEGRINI PR, RUDIN M, PERRY VH, MIR AK, WIESSNER C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002; 22: 308-317. (Pubitemid 34203058)
24. STRECKER JK, MINNERUP J, GESS B, RINGELSTEIN EB, SCHÄBITZ WR, SCHILLING M. Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice. PLoS One 2011; 6: e25863.
25. CAO CX, YANG QW, LV FL, CUI J, FU HB, WANG JZ. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor4 deficient mice. Biochem Biophys Res Commun 2007; 353: 509-514. (Pubitemid 46023466)
26. BERGER C, XIA F, MAURER MH, SCHWAB S. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev 2008: 58: 48-56. (Pubitemid 351852927)
27. KAWAI H, DEGUCHI S, DEGUCHI K, YAMASHITA T, OHTA Y, SHANG J, TIAN F, ZHANG X, LIU N, LIU W, IKEDA Y, MATSUURA T, ABE K. Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat. Brain Res 2011; 1368: 317-323.
28. MIAO H, JIANG L, HUANG L. Effects of simvastatin on the expression of intercellular adhesion molecule-1 mRNA in neonatal brain with hypoxic-ischemic damage. J Nanosci Nanotechnol 2005; 5: 1261-1265 (Pubitemid 44502141)
29. YANG J, HUANG C, YANG J, JIANG H, DING J. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NF-kB signaling pathway. Mol Cell Biochem 2010; 345: 189-195.
30. MAYANAGI K, KATAKAM PV, GÁSPÁR T, DOMOKI F, BUSIJA DW. Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 1927-1935.
31. SHIODA N, HAN F, MORIOKA M, FUKUNAGA K. Bis (1-oxy-2-pyridinethiolato) oxovanadium (IV) enhances neurogenesis via phosphatidylinositol 3- kinase/Akt and extracellular signal regulated kinase activation in the hippocampal subgranular zone after mouse focal cerebral ischemia. Neuroscience 2008; 155: 876-887.
32. CARLONI S, GIRELLI S, BUONOCORE G, LONGINI M, BALDUINI W. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 2009; 220: 82-89.
33. PRINZ V, LAUFS U, GERTZ K, KRONENBERG G, BALKAYA M, LEITHNER C, LINDAUER U, ENDRES M. Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke 2008; 39: 433-438. (Pubitemid 351619468)
34. ZHANG L, ZHANG ZG, LIU XS, HOZESKA-SOLGOT A, CHOPP M. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat. Arterioscler Thromb Vasc Biol 2007; 27: 2470-2475. (Pubitemid 350203966)
35. ASAHI M, HUANG Z, THOMAS S, YOSHIMURA S, SUMII T, MORI T, QIU J, AMIN-HANJANI S, HUANG P, LIAO JK, LO EH, MOSKOWITZ MA. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 722-729. (Pubitemid 40705607)
36. CAROD-ARTAL FJ. Statins and cerebral vasomotor reactivity: implications for a new therapy? Stroke 2006; 37: 2446-2448. (Pubitemid 44454653)
37. MORO MA, CARDENAS A, HURTADO O, LEZA JC, LIZASOAIN I. Role of nitric oxide after brain ischaemia. Cell Calcium 2004; 36: 265-275. (Pubitemid 38992352)
38. SIRONI L, CIMINO M, GUERRINI U, CALVIO AM, LODETTI B, ASDENTE M, BALDUINI W, PAOLETTI R, TREMOLI E. Treatment with statins after induction of focal is-chemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 2003; 23: 322-327. (Pubitemid 36231947)
39. KAWASHIMA S, YAMASHITA T, MIWA Y, OZAKI M, NAMIKI M, HIRASE T, INOUE N, HIRATA K, YOKOYAMA M. HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 2003; 34: 157-163. (Pubitemid 36070817)
40. LIAO JK, LAUFS U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005; 45: 89-118. (Pubitemid 40261799)
41. LAUFS U, GERTZ K, DIRNAGL U, BÖHM M, NICKENIG G, ENDRES M. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Research 2002: 942; 23-30. (Pubitemid 34597065)
42. SAWADA N, LIAO JK. Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection. Expert Rev Neurother 2009; 9: 1171-1186.
43. LAUFS U, ENDRES M, CUSTODIS F, GERTZ K, NICKENIG G, LIAO JK, BOHM M. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 2000; 102: 3104-3110.
44. ENDRES M, LAUFS U. Discontinuation of statin treatment in stroke patients. Stroke 2006; 37: 2640-2643. (Pubitemid 44454692)
45. HASHIGUCHI A, YANO S, MORIOKA M, HAMADA J, USHIO Y, TAKEUCHI Y, FUKUNAGA K. Up-regulation of endothelial nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 2004; 24: 271-279. (Pubitemid 38314583)
46. PENG B, GUO QL, HE ZJ, YE Z, YUAN YJ, WANG N, ZHOU J. Remote ischemic postconditioning protects the brain from global cerebral ischemia/ reperfusion injury by up-regulating endothelial nitric oxide synthase through the PI3K/Akt pathway. Brain Res 2012; 1445: 92-102
47. KUREISHI Y, LUO Z, SHIOJIMA I, BIALIK A, FULTON D, LEFER DJ, SESSA WC, WALSH K.The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 1004-1010.
48. MORIKAWA S, TAKABE W, MATAKI C, KANKE T, ITOH T, WADA Y, IZUMI SAITO Y, HAMAKUBO T, KODAMA T. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. J Atheroscler Thromb 2002; 9: 178-183.
49. HERNANDEZ-PERERA O, PEREZ-SALA D, NAVARRO-ANTOLIN J, SANCHEZ-PASCUALA R, HERNANDEZ G, DIAZ C, LAMAS S. Effects of the hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998; 101: 2711-2719. (Pubitemid 28294580)
50. OHKITA M, SUGII M, KA Y, KITAMURA A, MORI T, HAYASHI T, TAKAOKA M, MATSUMURA Y. Differential Effects of Different Statins on Endothelin-1 Gene Expression and Endothelial NOS Phosphorylation in Porcine Aortic Endothelial Cells. Exp Biol Med 2006; 231: 772-776. (Pubitemid 43845526)
51. CRACK PJ, TAYLOR JM. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 2005; 38: 1433-1444. (Pubitemid 40693828)
52. KONTOS HA. Oxygen radicals in cerebral ischemia: the 2001 Willis Lecture. Stroke 2001; 32: 2712-2716. (Pubitemid 33055333)
53. NANETTI L, TAFFI R, VIGNINI A, MORONI C, RAFFAELLI F, BACCHETTI T, SILVESTRINI M, PROVINCIALI L, MAZZANTI L. Reactive oxygen species plasmatic levels in ischemic stroke.Mol Cell Biochem 2007; 303: 19-25. (Pubitemid 47261297)
54. MUROTOMI K, TAKAGI N, TAKEO S, TANONAKA K. NADPH oxidase-mediated oxidative damage to proteins in the postsynaptic density after transient cerebral ischemia and reperfusion. Mol Cell Neurosci 2011; 46: 681-688.
55. RAZ L, ZHANG QG, ZHOU CF, HAN D, GULATI P, YANG LC, YANG F, WANG RM, BRANN DW. Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One 2010; 5: e12606.
56. WAGNER AH, KOHLER T, RUCKSCHLOSS U, JUST I, HECKER M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 2000; 20: 61-69. (Pubitemid 30048347)
57. HONG H, ZENG JS, KREULEN DL, KAUFMAN DI, CHEN AF. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am J Physiol Heart Circ Physiol 2006; 291: H2210-2215.
58. HAYASHI T, HAMAKAWA K, NAGOTANI S, JIN G, LI F, DEGUCHI K, SEHARA Y, ZHANG H, NAGANO I, SHOJI M, ABE K. HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons. Brain Res 2005; 1037: 52-58. (Pubitemid 40362381)
59. NAGOTANI S, HAYASHI T, SATO K, ZHANG W, DEGUCHI K, NAGANO I, SHOJI M, ABE K. Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress. Stroke 2005; 36: 670-672. (Pubitemid 40344176)
60. SUGAWARA T, CHAN PH. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxidants and Redox Signaling 2003; 5: 597-607. (Pubitemid 37315148)
61. ZHANG YY, YU QH, YOU S, SHENG L, WANG YM, WAN YL. Influence of Terpene Lactons treatment on brain lipid peroxidation and antioxidant defense systems of rats after focal ischemia. Indian J Pharma Sci 2002, 64: 573-578.
62. KUMAGAI R, OKI C, MURAMATSU Y, KUROSAKI R, KATO H, ARAKI T. Pitavastatin, a 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase inhibitor, reduces hippocampal damage after transient cerebral ischemia in gerbils. J Neural Transm 2004; 111: 1103-1120. (Pubitemid 39222772)
63. BERETTA S, PASTORI C, SALA G, PIAZZA F, FERRARESE C, CATTALINI A, DE CURTIS M, LIBRIZZI L. Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia. Neuropharmacology 2011; 60: 878-885.
64. NITO C, KAMADA H, ENDO H, NIIZUMA K, MYER DJ, CHAN PH. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2008; 28: 1686-1696.
65. CUI LL, ZHANG XJ, YANG R, WANG LN, LIU LL, LI M, DU W. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: Down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res 2010; 1325: 164-173.
66. CÉSPEDES-RUBIO A, JURADO FW, CARDONA-GÓMEZ GP, CARDONA-GÓMEZ GP. p120-catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia. J Neurosci Res 2010; 88: 3621-3634.
67. ZHANG YY, SHI LL, HAO DH, PAN LH. The actions of Bcl-2 on anti-ischemic neuron injury and the effects of anti-ischemic drugs on Bcl-2. Chin Pharmacol Bull 2010; 26: 21-24.
68. CARLONI S, MAZZONI E, CIMINO M, SIMONI MG, PEREGO C, SCOPA C, BALDUINI W. Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat. Neurobiol Dis 2006; 21: 119-126. (Pubitemid 41817312)
69. ALAM MM, MOHAMMAD AA, SHUAIB U, WANG CX, GHANI U, SCHWINDT B, TODD KG, SHUAIB A. Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis. J Cereb Blood Flow Metab 2009; 29: 157-165.
70. BAO XM, WU CF, LU GP. Atorvastatin inhibits homocysteine- induced dysfunction and apoptosis in endothelial progenitor cells. Acta Pharmacol Sin 2010; 31: 476-484.
71. ZHANG R, XUE YY, LU SD, WANG Y, ZHANG LM, HUANG YL, SIGNORE AP, CHEN J, SUN FY. Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiol Dis 2006; 24: 345-356. (Pubitemid 44572753)
72. FRANKE C, NTILDNER M, ABDEL-KADER R. Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin. Neurobiol Dis 2007; 25: 438-445. (Pubitemid 46138047)
73. JOHNSON-ANUNA LN, ECKERT GP, FRANKE C, IGBAVBOA U, MULLER WE, WOOD WG. Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem 2007; 101: 77-86. (Pubitemid 46426484)
74. BUTTERICK TA, IGBAVBOA U, ECKERT GP, SUN GY, WEISMAN GA, MÜLLER WE, WOOD WG. Simvastatin stimulates production of the antiapoptotic protein Bcl- 2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol 2010; 41: 384-391.
75. BARYAN HK, ALLAN SM, VAIL A, SMITH CJ. Systematic review and meta-analysis of the efficacy of statins in experimental stroke. Int J Stroke 2012; 7: 150-156.